Niva Bupa’s Stellar H1FY25 Performance Outpaces Industry Growth

Niva Bupa Health Insurance has showcased a strong performance in the first half of FY25 (H1FY25), far surpassing the growth rate of the Indian health insurance industry. With a gross written premium (GWP) of ₹3,241 crore, the company recorded a 33% year-on-year (YoY) growth compared to the industry’s 10%. New business grew by 40%, driven by a 7-8% increase in pricing and substantial volume growth from new policyholders.

The company attributes this robust growth to a fourfold increase in its sales and agency workforce over the past few years, alongside strengthened bancassurance partnerships. This growth strategy has clearly paid dividends, positioning the company as a leader in the health insurance sector.

Improved Profitability and Investment Returns

Niva Bupa’s profit after tax (PAT) in H1FY25 surged to ₹59.5 crore, more than double the ₹27.6 crore recorded a year ago, as per International Financial Reporting Standards. A significant factor in this profitability boost was prudent fund management, leading to an annualized investment yield of 7.5%, up from 7% in the previous year. The rise in yield was achieved through a focus on higher-duration investments without relying on equity holdings. Management anticipates this yield to remain steady in the foreseeable future.

Operational Efficiency and Combined Ratio

The company’s combined ratio—a key measure of operational efficiency—improved to 103.5% from 104.7% a year earlier. This was driven by a decrease in the claims ratio to 62.5% from 63.8%. While management expenses were flat at 40% of GWP, exceeding the regulatory cap of 36%, Niva Bupa plans to address this issue with a dual approach: reducing fixed costs and boosting premium income.

To achieve the latter, the company has implemented a 10% premium hike on 35% of its retail health product portfolio, which is expected to contribute significantly to revenue growth.

Solvency and Market Position

The company’s solvency ratio improved to 2.25x, comfortably above the regulatory requirement of 1.5x. This improvement was supported by proceeds from its recent public issue, providing the company with a stronger capital base to undertake more business.

In terms of valuation, Niva Bupa’s market capitalization of ₹13,800 crore is three times its annualized net earned premium (NEP) for H1FY25. While its NEP growth of 36% is higher than its larger competitor’s 16%, the current valuation already reflects this growth potential, suggesting limited room for immediate upside.

Niva Bupa’s Share Price Performance 

As of November 28, Niva Bupa’s share price are trading at ₹74.91, down by 0.32% from the previous day’s close. The day’s trading range saw the stock fluctuate between a low of ₹74.00 and a high of ₹79.00. The share price opened at ₹75.19, showing modest activity near its issue price of ₹74.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.